Bristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh
Tiada dagangan
Bon BMY
Di bawah adalah senarai bon-bon korporat Bristol-Myers Squibb Company Shs Cert Deposito Arg Repr 0.333333 Sh. Pelabur selalunya memilih bon syarikat kerana kestabilan meningkat mereka semasa ketidakstabilan pasaran. Kaji harga, hasil dan statistik lain dan cari pelaburan yang boleh dipercayai.
Simbol | YTM % | Volum | Harga % | Kupon % | Tarikh Matang | Jumlah tertunggak | Nilai muka | Jumlah denominasi min | Pengeluar |
---|---|---|---|---|---|---|---|---|---|
— | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 2.72 M | 97.55% | 3.40% | 2029-07-26 | 2.37 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 3.41 M | 85.73% | 4.55% | 2048-02-20 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 13 K | 99.28% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 104.25% | 3.20% | 2026-06-15 | 5.95 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 259 K | 93.16% | 5.00% | 2045-08-15 | 741.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 11 K | 103.38% | 5.70% | 2040-10-15 | 151.01 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | — | 97 K | 99.13% | 3.90% | 2028-02-20 | 43.84 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 15 K | 113.79% | 6.88% | 2097-08-01 | 62.42 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
— | 25 K | 83.51% | 4.35% | 2047-11-15 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 432 K | 89.04% | 4.13% | 2039-06-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 65 K | 99.26% | 3.45% | 2027-11-15 | 517.67 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 5.79 M | 80.14% | 4.25% | 2049-10-26 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | — | 5 K | 80.09% | 4.35% | 2047-11-15 | 13.57 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 4.4 M | 100.02% | 4.84% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | — | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.2 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 3.97 M | 99.21% | 3.20% | 2026-06-15 | 1.74 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 750 K | 95.71% | 3.40% | 2029-07-26 | 26.56 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | — | 8 K | 87.60% | 5.00% | 2045-08-15 | 15.71 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 4.3 M | 100.00% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | — | 10 K | 93.18% | 5.70% | 2040-10-15 | 2.3 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 2 K | 106.08% | 6.13% | 2038-05-01 | 219.25 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | — | 100 K | 79.04% | 4.63% | 2044-05-15 | 3.69 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 40 K | 108.24% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 20 K | 103.18% | 6.80% | 2026-11-15 | 255.95 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | — | 10 K | 98.60% | 3.45% | 2027-11-15 | 16.55 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 50 K | 76.05% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | — | 30 K | 82.51% | 5.25% | 2043-08-15 | 4.06 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
— | 20 K | 98.90% | 5.25% | 2043-08-15 | 218.37 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 309 K | 87.41% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 235 K | 88.37% | 4.63% | 2044-05-15 | 744.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 72.05% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 102.77% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 86.37% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 107.60% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 106.76% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 106.01% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 100.17% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 85.92% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
— | 0 | 94.36% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 98.75% | 3.25% | 2027-02-27 | 512.28 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 78.75% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 101.13% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 99.28% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 70.53% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 96.78% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 102.62% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 91.18% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 103.80% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 57.80% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 96.92% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 68.93% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
— | 0 | 106.78% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |